
[Cancer Research 57, 2029-2034, May 15, 1997]
© 1997 American Association for Cancer Research
Identification of a Gene Containing Zinc-Finger Motifs Based on Lost Expression in Malignantly Transformed Rat Ovarian Surface Epithelial Cells1
Abbas Abdollahi,
Andrew K. Godwin,
Paul D. Miller,
Lori A. Getts,
David C. Schultz,
Takahiro Taguchi,
Joseph R. Testa and
Thomas C. Hamilton2
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [A.A., A.K.G., P.D.M., L.A.G., D.C.S., T.T., J.R.T., T.C.H.], and Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania 18015 [L.A.G., D.C.S., T.C.H.]
We have used a rat model of epithelial ovarian cancer to identify a gene that shows decreased or lost expression in five of eight independently transformed rat ovarian surface epithelial cell lines compared to the normal progenitor cells. Hence, we refer to this gene as Lot1 (lost on transformation 1; GenBank accession no. U72620). The most abundant transcript of the gene is
6 kb. This sequence contains a 1749-nucleotide open reading frame and, within the 3' untranslated region, 22 near-perfect 6070-bp repeats and adenine- and uracil-rich areas. The deduced amino acid sequence from the open reading frame contains seven zinc-finger motifs of the C2H2 type, as well as proline-, glutamine-, and glutamic acid-rich areas. The gene maps to the short arm of chromosome one in the rat. Lot1 shows a limited distribution of expression in normal rat tissues, including ovary, which shows abundant expression. Furthermore, examination of DNA derived from multiple species indicates that the gene is widely conserved.
1 The work was supported by NIH Grant CA60643 and a Hoxie Harrison Smith grant (to A. K. G.). T. C. H. was supported by NIH Grant CA56916 and by the Evy Lessin Fund For Ovarian Cancer Research.
2 To whom requests for reprints should be addressed, at Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111. Phone: (215) 728-2856; Fax: (215) 728-2741.
Received 1/ 6/97.
Accepted 3/24/97.
This article has been cited by other articles:

|
 |

|
 |
 
P.-Y. Liu, J. Y.-H. Chan, H.-C. Lin, S.-L. Wang, S.-T. Liu, C.-L. Ho, L.-C. Chang, and S.-M. Huang
Modulation of the Cyclin-Dependent Kinase Inhibitor p21WAF1/Cip1 Gene by Zac1 through the Antagonistic Regulators p53 and Histone Deacetylase 1 in HeLa Cells
Mol. Cancer Res.,
July 1, 2008;
6(7):
1204 - 1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C.K. Leung and J.-H. Choi
Endocrine signaling in ovarian surface epithelium and cancer
Hum. Reprod. Update,
March 1, 2007;
13(2):
143 - 162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Barz, A. Hoffmann, M. Panhuysen, and D. Spengler
Peroxisome Proliferator-Activated Receptor {gamma} Is a Zac Target Gene Mediating Zac Antiproliferation
Cancer Res.,
December 15, 2006;
66(24):
11975 - 11982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hoffmann, T. Barz, and D. Spengler
Multitasking C2H2 Zinc Fingers Link Zac DNA Binding to Coordinated Regulation of p300-Histone Acetyltransferase Activity.
Mol. Cell. Biol.,
July 1, 2006;
26(14):
5544 - 5557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Theodoropoulou, J. Zhang, S. Laupheimer, M. Paez-Pereda, C. Erneux, T. Florio, U. Pagotto, and G. K. Stalla
Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression
Cancer Res.,
February 1, 2006;
66(3):
1576 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Contestabile, T. Fila, R. Bartesaghi, and E. Ciani
Cyclic AMP-mediated Regulation of Transcription Factor Lot1 Expression in Cerebellar Granule Cells
J. Biol. Chem.,
September 30, 2005;
280(39):
33541 - 33551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Basyuk, V. Coulon, A. Le Digarcher, M. Coisy-Quivy, J.-P. Moles, A. Gandarillas, and L. Journot
The Candidate Tumor Suppressor Gene ZAC Is Involved in Keratinocyte Differentiation and Its Expression Is Lost in Basal Cell Carcinomas
Mol. Cancer Res.,
September 1, 2005;
3(9):
483 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Arima, T. Kamikihara, T. Hayashida, K. Kato, T. Inoue, Y. Shirayoshi, M. Oshimura, H. Soejima, T. Mukai, and N. Wake
ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome
Nucleic Acids Res.,
May 11, 2005;
33(8):
2650 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Garson, E. Macdonald, M. Dube, R. Bao, T. C. Hamilton, and B. C. Vanderhyden
Generation of Tumors in Transgenic Mice Expressing the SV40 T Antigen Under the Control of Ovarian-Specific Promoter 1
Reproductive Sciences,
May 1, 2003;
10(4):
244 - 250.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abdollahi, D. Pisarcik, D. Roberts, J. Weinstein, P. Cairns, and T. C. Hamilton
LOT1 (PLAGL1/ZAC1), the Candidate Tumor Suppressor Gene at Chromosome 6q24-25, Is Epigenetically Regulated in Cancer
J. Biol. Chem.,
February 14, 2003;
278(8):
6041 - 6049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hoffmann, E. Ciani, J. Boeckardt, F. Holsboer, L. Journot, and D. Spengler
Transcriptional Activities of the Zinc Finger Protein Zac Are Differentially Controlled by DNA Binding
Mol. Cell. Biol.,
February 1, 2003;
23(3):
988 - 1003.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. Li, Z. H. Meng, A. Sayeed, R. Shalaby, B.-M. Ljung, and S. H. Dairkee
Genome-wide Allelotyping of a New in Vitro Model System Reveals Early Events in Breast Cancer Progression
Cancer Res.,
October 15, 2002;
62(20):
5980 - 5987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Braem, K. Kas, E. Meyen, M. Debiec-Rychter, W. J. M. Van de Ven, and M. L. Voz
Identification of a Karyopherin alpha 2 Recognition Site in PLAG1, Which Functions As a Nuclear Localization Signal
J. Biol. Chem.,
May 24, 2002;
277(22):
19673 - 19678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mizutani, T. Furukawa, Y. Adachi, S. Ikehara, and S. Taketani
A Zinc-finger Protein, PLAGL2, Induces the Expression of a Proapoptotic Protein Nip3, Leading to Cellular Apoptosis
J. Biol. Chem.,
May 3, 2002;
277(18):
15851 - 15858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Joseph, Y.-X. Lei, W.-Z. Whong, and T.-m. Ong
Molecular Cloning and Functional Analysis of a Novel Cadmium-responsive Proto-oncogene
Cancer Res.,
February 1, 2002;
62(3):
703 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Kolluri, C. Balduf, M. Hofmann, and M. Gottlicher
Novel Target Genes of the Ah (Dioxin) Receptor: Transcriptional Induction of N-Myristoyltransferase 2
Cancer Res.,
December 1, 2001;
61(23):
8534 - 8539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Arima, R. A. Drewell, K. L. Arney, J. Inoue, Y. Makita, A. Hata, M. Oshimura, N. Wake, and M. A. Surani
A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus
Hum. Mol. Genet.,
July 1, 2001;
10(14):
1475 - 1483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Barghorn, E. J. M. Speel, B. Farspour, P. Saremaslani, S. Schmid, A. Perren, J. Roth, P. U. Heitz, and P. Komminoth
Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors
Am. J. Pathol.,
June 1, 2001;
158(6):
1903 - 1911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Hough, K. R. Cho, A. B. Zonderman, D. R. Schwartz, and P. J. Morin
Coordinately Up-Regulated Genes in Ovarian Cancer
Cancer Res.,
May 1, 2001;
61(10):
3869 - 3876.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Selvakumaran, R. Bao, A. P. G. Crijns, D. C. Connolly, J. K. Weinstein, and T. C. Hamilton
Ovarian Epithelial Cell Lineage-specific Gene Expression Using the Promoter of a Retrovirus-like Element
Cancer Res.,
February 1, 2001;
61(4):
1291 - 1295.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Kotaja, S. Aittomäki, O. Silvennoinen, J. J. Palvimo, and O. A. Jänne
ARIP3 (Androgen Receptor-Interacting Protein 3) and Other PIAS (Protein Inhibitor of Activated STAT) Proteins Differ in Their Ability to Modulate Steroid Receptor-Dependent Transcriptional Activation
Mol. Endocrinol.,
December 1, 2000;
14(12):
1986 - 2000.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
U. Pagotto, T. Arzberger, M. Theodoropoulou, Y. Grübler, C. Pantaloni, W. Saeger, M. Losa, L. Journot, G. K. Stalla, and D. Spengler
The Expression of the Antiproliferative Gene ZAC Is Lost or Highly Reduced in Nonfunctioning Pituitary Adenomas
Cancer Res.,
December 1, 2000;
60(24):
6794 - 6799.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. D. Hough, C. A. Sherman-Baust, E. S. Pizer, F. J. Montz, D. D. Im, N. B. Rosenshein, K. R. Cho, G. J. Riggins, and P. J. Morin
Large-Scale Serial Analysis of Gene Expression Reveals Genes Differentially Expressed in Ovarian Cancer
Cancer Res.,
November 1, 2000;
60(22):
6281 - 6287.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Suzuki, D. H. Moore II, D. G. Ginzinger, T. E. Godfrey, J. Barclay, B. Powell, D. Pinkel, C. Zaloudek, K. Lu, G. Mills, et al.
An Approach to Analysis of Large-Scale Correlations between Genome Changes and Clinical Endpoints in Ovarian Cancer
Cancer Res.,
October 1, 2000;
60(19):
5382 - 5385.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-M. Huang and M. R. Stallcup
Mouse Zac1, a Transcriptional Coactivator and Repressor for Nuclear Receptors
Mol. Cell. Biol.,
March 1, 2000;
20(5):
1855 - 1867.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. L. Voz, N. S. Agten, W. J. M. Van de Ven, and K. Kas
PLAG1, the Main Translocation Target in Pleomorphic Adenoma of the Salivary Glands, Is a Positive Regulator of IGF-II
Cancer Res.,
January 1, 2000;
60(1):
106 - 113.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Maebayashi, Y. Shigeyoshi, T. Takumi, and H. Okamura
A Putative Transcription Factor with Seven Zinc-Finger Motifs Identified in the Developing Suprachiasmatic Nucleus by the Differential Display PCR Method
J. Neurosci.,
November 15, 1999;
19(22):
10176 - 10183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Bruening, A. H. Prowse, D. C. Schultz, M. Holgado-Madruga, A. Wong, and A. K. Godwin
Expression of OVCA1, a Candidate Tumor Suppressor, Is Reduced in Tumors and Inhibits Growth of Ovarian Cancer Cells
Cancer Res.,
October 1, 1999;
59(19):
4973 - 4983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Pagotto, T. Arzberger, E. Ciani, F. Lezoualch, C. Pilon, L. Journot, D. Spengler, and G. K. Stalla
Inhibition of Zac1, a New Gene Differentially Expressed in the Anterior Pituitary, Increases Cell Proliferation
Endocrinology,
February 1, 1999;
140(2):
987 - 996.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Abdollahi, L. A. Getts, G. Sonoda, P. D. Miller, T. Taguchi, A. K. Godwin, J. R. Testa, and T. C. Hamilton
Genome Scanning Detects Amplification of the Cathepsin B Gene (CtsB) in Transformed Rat Ovarian Surface Epithelial Cells
Reproductive Sciences,
January 1, 1999;
6(1):
32 - 40.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kas, M. L. Voz, K. Hensen, E. Meyen, and W. J. M. Van de Ven
Transcriptional Activation Capacity of the Novel PLAG Family of Zinc Finger Proteins
J. Biol. Chem.,
September 4, 1998;
273(36):
23026 - 23032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Varrault, E. Ciani, F. Apiou, B. Bilanges, A. Hoffmann, C. Pantaloni, J. Bockaert, D. Spengler, and L. Journot
hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer
PNAS,
July 21, 1998;
95(15):
8835 - 8840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Varrault, B. Bilanges, D. J. G. Mackay, E. Basyuk, B. Ahr, C. Fernandez, D. O. Robinson, J. Bockaert, and L. Journot
Characterization of the Methylation-sensitive Promoter of the Imprinted ZAC Gene Supports Its Role in Transient Neonatal Diabetes Mellitus
J. Biol. Chem.,
May 25, 2001;
276(22):
18653 - 18656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Association for Cancer Research.